Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperuricemia in hypertension].

I Tatsuno1, Y Saito

  • 1Second Department of Internal Medicine, Chiba University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|June 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased sensitivity of glioblastoma cells to interleukin 1 after long-term incubation with dexamethasone.

Molecular and cellular neurosciences·2009
Same author

MRI of ectopic posterior pituitary bright spot with large adenomas: appearances and relationship to transient postoperative diabetes insipidus.

Neuroradiology·2003
Same author

[Primary aldosteronism].

Nihon rinsho. Japanese journal of clinical medicine·2002
Same author

toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype.

Infection and immunity·2001
Same author

Recurrent neurohypophyseal germinoma causing invasion localized to temporal bone marrow-unreported neuroimaging studies compared to autopsy findings.

Acta neurochirurgica·2001
Same author

Involvement of PACAP receptor in primary afferent fibre-evoked responses of ventral roots in the neonatal rat spinal cord.

British journal of pharmacology·2001
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Hyperuricemia is linked to hypertension and cardiovascular risks. Careful diuretic selection and combination therapy are crucial to prevent treatment-induced hyperuricemia in hypertensive patients.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Endocrinology

Context:

  • Hyperuricemia frequently complicates hypertension, with a bidirectional relationship observed.
  • Hyperuricemia is increasingly recognized as a risk factor for cardiovascular events in hypertensive individuals.
  • Diuretics, commonly used for hypertension and heart failure, can induce or exacerbate hyperuricemia.

Purpose:

  • To highlight the critical role of hyperuricemia management in hypertension treatment.
  • To emphasize the need for careful consideration of diuretic therapy in hypertensive patients with hyperuricemia.
  • To advocate for antihypertensive drug selection that does not adversely affect uric acid levels.

Summary:

  • The study underscores the close correlation between hyperuricemia and hypertension, noting its role as a cardiovascular risk factor.

Related Experiment Videos

  • It addresses the challenge posed by diuretics, which can induce hyperuricemia, necessitating cautious use and combination therapies.
  • The findings suggest that antihypertensive medications should be chosen based on their impact on uric acid concentration.

    • Impact:

    • Informing clinical practice regarding the management of hypertension with co-existing hyperuricemia.
    • Guiding the selection of antihypertensive agents to mitigate cardiovascular risks associated with uric acid levels.
    • Promoting therapeutic strategies that prevent treatment-induced hyperuricemia, thereby improving patient outcomes.